
Psychiatr Serv 59:1139-1147, October 2008
doi: 10.1176/appi.ps.59.10.1139
© 2008 American Psychiatric Association
Guideline-Consistent Antidepressant Treatment Patterns Among Veterans With Diabetes and Major Depressive Disorder
Anjali Tiwari, M.B.B.S., M.S.,
Mangala Rajan, M.B.A.,
Donald Miller, Sc.D.,
Leonard Pogach, M.D.,
Mark Olfson, M.D., M.P.H. and
Usha Sambamoorthi, Ph.D.
Dr. Tiwari, Ms. Rajan, Dr. Pogach, and Dr. Sambamoorthi are affiliated with the Health Services Research and Development Center for Health Care Knowledge and Management, New Jersey Health Care System, Department of Veteran Affairs (VA), East Orange, New Jersey. Dr. Sambamoorthi is also with the Department of Psychiatry, University of Massachusetts Medical School, Worcester. Dr. Miller is with the Center for Health Quality, Outcomes, and Economic Research, VA, Bedford, Massachusetts. Dr. Olfson is with the Department of Psychiatry, Columbia University, New York City. Send correspondence to Dr. Sambamoorthi at the Health Services Research and Development Center for Health Care Knowledge and Management, New Jersey Health Care System, VA, 385 Tremont Ave., Mail Stop 129, East Orange, NJ 07018 (e-mail: usha.sambamoorthi{at}umassmed.edu).
OBJECTIVE: This study estimated guideline-consistent antidepressant treatment of depression among veterans with diabetes and examined its variation by patient-level demographic characteristics, socioeconomic characteristics, access to care, and health status. METHODS: Data were retrospectively analyzed from Veterans Health Administration (VHA) and Medicare claims of VHA clinic users with diabetes and major depressive disorder (N=3,953). Major depression was identified by using ICD-9-CM codes 296.2 and 296.3. Incident episode was identified by using 120-day negative diagnosis and medication history on or before the first depression diagnosis date in fiscal year 1999. Guideline-consistent depression treatment was defined as the receipt of antidepressants for at least 90 days within a period of six months after the onset of depression. Chi square tests and logistic regressions were used to analyze patterns of guideline-consistent antidepressant treatment. RESULTS: Overall, 51% received any antidepressant treatment for diagnosed major depression; among patients using any antidepressants, 62% received guideline-consistent antidepressant treatment. VHA users who received care from a mental health specialist were more likely to have guideline-consistent treatment than those who were not receiving care from a mental health specialist. African Americans, older veterans, and those with substance use disorders were less likely to have guideline-consistent antidepressant treatment. CONCLUSIONS: Guideline-consistent depression care was lower for certain subgroups of individuals. Further research is necessary to evaluate the reasons for this finding, so that targeted care coordination strategies could be developed to improve antidepressant treatment. Increased contact with mental health specialty staff, which is now being implemented in the VHA, may increase antidepressant treatment among VHA users with diabetes and major depression.
Related Articles:
-
October 2008: This Month's Highlights
Psychiatr Serv 2008 59: 1089.
[Full Text]
[PDF]
-
Meta-analysis of Major Depressive Disorder Relapse and Recurrence With Second-Generation Antidepressants
- Richard Hansen, Bradley Gaynes, Patricia Thieda, Gerald Gartlehner, Angela Deveaugh-Geiss, Erin Krebs, and Kathleen Lohr
Psychiatr Serv 2008 59: 1121-1130.
[Abstract]
[Full Text]
[PDF]
-
Antidepressant Use in Black and White Populations in the United States
- Hector M. González, Thomas Croghan, Brady West, David Williams, Randolph Nesse, Wassim Tarraf, Robert Taylor, Ladson Hinton, Harold Neighbors, and James Jackson
Psychiatr Serv 2008 59: 1131-1138.
[Abstract]
[Full Text]
[PDF]
-
Changing Trends in Pediatric Antipsychotic Use in Florida's Medicaid Program
- Robert Constantine and Rajiv Tandon
Psychiatr Serv 2008 59: 1162-1168.
[Abstract]
[Full Text]
[PDF]
-
Trends in Use of Antipsychotics and Mood Stabilizers Among Medicaid Beneficiaries With Bipolar Disorder, 2001–2004
- Colin Depp, Victoria D. Ojeda, William Mastin, Jürgen Unützer, and Todd P. Gilmer
Psychiatr Serv 2008 59: 1169-1174.
[Abstract]
[Full Text]
[PDF]
-
Psychotropic Medications for Patients With Bipolar Disorder in the United States: Polytherapy and Adherence
- Ross Baldessarini, Henry Henk, Ami Sklar, Jane Chang, and Leslie Leahy
Psychiatr Serv 2008 59: 1175-1183.
[Abstract]
[Full Text]
[PDF]
-
Pharmacologic Treatment of Posttraumatic Stress Disorder Among Privately Insured Americans
- Ilan Harpaz-Rotem, Robert A. Rosenheck, Somaia Mohamed, and Rani A. Desai
Psychiatr Serv 2008 59: 1184-1190.
[Abstract]
[Full Text]
[PDF]
-
Dosing Frequency and Adherence to Antipsychotic Medications
- Paul N. Pfeiffer, Dara Ganoczy, and Marcia Valenstein
Psychiatr Serv 2008 59: 1207-1210.
[Abstract]
[Full Text]
[PDF]
Get information about faster international access.
a>
Privacy Policy
Copyright © 2008
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|